Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANXIOUS PATIENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 45 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ballenger, JC
      Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder

      JOURNAL OF CLINICAL PSYCHIATRY
    2. Hidalgo, RB; Davidson, JRT
      Generalized anxiety disorder - An important clinical concern

      MEDICAL CLINICS OF NORTH AMERICA
    3. Rocca, P; Beoni, AM; Eva, C; Ferrero, P; Maina, G; Bogetto, F; Ravizza, L
      Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Nudmamud, S; Siripurkpong, P; Chindaduangratana, C; Harnyuttanakorn, P; Lotrakul, P; Laarbboonsarp, W; Srikiatkhachorn, A; Kotchabhakdi, N; Casalotti, SO
      Stress, anxiety and peripheral benzodiazepine receptor mRNA levels in human lymphocytes

      LIFE SCIENCES
    5. Janzen, PRM; Hall, WJ; Hopkins, PM
      Setting targets for sedation with a target-controlled propofol infusion

      ANAESTHESIA
    6. Soreni, N; Apter, A; Weizman, A; Don-Tufeled, O; Leschiner, S; Karp, L; Gavish, M
      Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts

      BIOLOGICAL PSYCHIATRY
    7. Wodarz, N; Rothenhofer, C; Fischer, R; Stober, G; Kiehl, B; Jungkunz, G; Riederer, P; Klein, HE
      Peripheral-type benzodiazepine receptors in diagnostic subtypes of schizophrenic patients

      PSYCHIATRY RESEARCH
    8. JOHNSON MR; MARAZZITI D; BRAWMANMINTZER O; EMMANUEL NP; WARE MR; MORTON WA; ROSSI A; CASSANO GB; LYDIARD RB
      ABNORMAL PERIPHERAL BENZODIAZEPINE RECEPTOR DENSITY ASSOCIATED WITH GENERALIZED SOCIAL PHOBIA

      Biological psychiatry
    9. ROCCA P; BEONI AM; EVA C; FERRERO P; ZANALDA E; RAVIZZA L
      PERIPHERAL BENZODIAZEPINE RECEPTOR MESSENGER-RNA IS DECREASED IN LYMPHOCYTES OF GENERALIZED ANXIETY DISORDER PATIENTS

      Biological psychiatry
    10. Conner, KM; Davidson, JRT
      Generalized anxiety disorder: Neurobiological and pharmacotherapeutic perspectives

      BIOLOGICAL PSYCHIATRY
    11. FULTON B; BROGDEN RN
      BUSPIRONE - AN UPDATED REVIEW OF ITS CLINICAL-PHARMACOLOGY AND THERAPEUTIC APPLICATIONS

      CNS DRUGS
    12. HANNA GL; FEIBUSCH EL; ALBRIGHT KJ
      BUSPIRONE TREATMENT OF ANXIETY ASSOCIATED WITH PHARYNGEAL DYSPHAGIA IN A 4-YEAR-OLD

      Journal of child and adolescent psychopharmacology
    13. HOEHN T; BRAUNE S; SCHEIBE G; ALBUS M
      PHYSIOLOGICAL, BIOCHEMICAL AND SUBJECTIVE PARAMETERS IN ANXIETY PATIENTS WITH PANIC DISORDER DURING STRESS EXPOSURE AS COMPARED WITH HEALTHY CONTROLS

      European archives of psychiatry and clinical neuroscience
    14. SUNDSTROM I; NYBERG S; BACKSTROM T
      PATIENTS WITH PREMENSTRUAL-SYNDROME HAVE REDUCED SENSITIVITY TO MIDAZOLAM COMPARED TO CONTROL SUBJECTS

      Neuropsychopharmacology
    15. SALETU B; SALETUZYHLARZ G; ANDERER P; BRANDSTATTER N; FREY R; GRUBER G; KLOSCH G; MANDL M; GRUNBERGER J; LINZMAYER L
      NONORGANIC INSOMNIA IN GENERALIZED ANXIETY DISORDER .2. COMPARATIVE-STUDIES ON SLEEP, AWAKENING, DAYTIME VIGILANCE AND ANXIETY UNDER LORAZEPAM PLUS DIPHENHYDRAMINE (SOMNIUM(R)) VERSUS LORAZEPAM ALONE, UTILIZING CLINICAL, POLYSOMNOGRAPHIC AND EEG MAPPING METHODS

      Neuropsychobiology
    16. BRAWMANMINTZER O; LYDIARD RB; RICKELS; SMALL
      BIOLOGICAL BASIS OF GENERALIZED ANXIETY DISORDER

      The Journal of clinical psychiatry
    17. RICKELS K; SCHWEIZER E
      THE CLINICAL PRESENTATION OF GENERALIZED ANXIETY IN PRIMARY-CARE SETTINGS - PRACTICAL CONCEPTS OF CLASSIFICATION AND MANAGEMENT

      The Journal of clinical psychiatry
    18. PECKNOLD JC
      A RISK-BENEFIT ASSESSMENT OF BUSPIRONE IN THE TREATMENT OF ANXIETY DISORDERS

      Drug safety
    19. GOULD RA; OTTO MW; POLLACK MH; YAP L
      COGNITIVE-BEHAVIORAL AND PHARMACOLOGICAL TREATMENT OF GENERALIZED ANXIETY DISORDER - A PRELIMINARY METAANALYSIS

      Behavior therapy
    20. BREMNER JD; KRYSTAL JH; SOUTHWICK SM; CHARNEY DS
      NORADRENERGIC MECHANISMS IN STRESS AND ANXIETY .2. CLINICAL-STUDIES

      Synapse
    21. BOERNER RJ
      BUSPIRONE IN THE THERAPY OF GENERALIZED A NXIETY DISORDER WITH ALCOHOL-ABUSE AND AGORAPHOBIA

      Nervenheilkunde
    22. BURGIN R; WEIZMAN R; GAVISH M
      REPEATED SWIM STRESS AND PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS

      Neuropsychobiology
    23. POURMOTABBED T; MCLEOD DR; HOEHNSARIC R; HIPSLEY P; GREENBLATT DJ
      TREATMENT, DISCONTINUATION, AND PSYCHOMOTOR EFFECTS OF DIAZEPAM IN WOMEN WITH GENERALIZED ANXIETY DISORDER

      Journal of clinical psychopharmacology
    24. ANDERSON GM
      EFFECTIVENESS OF PINDOLOL WITH SELECTED ANTIDEPRESSANT DRUGS IN THE TREATMENT OF MAJOR DEPRESSION - COMMENT

      Journal of clinical psychopharmacology
    25. BITSIOS P; SZABADI E; BRADSHAW CM
      THE INHIBITION OF THE PUPILLARY LIGHT REFLEX BY THE THREAT OF AN ELECTRIC-SHOCK - A POTENTIAL LABORATORY MODEL OF HUMAN ANXIETY

      JOURNAL OF PSYCHOPHARMACOLOGY
    26. GORENSTEIN C; ANDRADE L
      VALIDATION OF A PORTUGUESE VERSION OF THE BECK DEPRESSION INVENTORY AND THE STATE-TRAIT ANXIETY INVENTORY IN BRAZILIAN SUBJECTS

      Brazilian journal of medical and biological research
    27. CAMERON OG; SMITH CB; NESSE RM; HILL EM; HOLLINGSWORTH PJ; ABELSON JA; HARIHARAN M; CURTIS GC
      PLATELET ALPHA-2-ADRENOCEPTORS, CATECHOLAMINES, HEMODYNAMIC VARIABLES, AND ANXIETY IN PANIC PATIENTS AND THEIR ASYMPTOMATIC RELATIVES

      Psychosomatic medicine
    28. BEAUMONT G
      CLOBAZAM IN THE TREATMENT OF ANXIETY

      Human psychopharmacology
    29. ALLAN CA
      ALCOHOL-PROBLEMS AND ANXIETY DISORDERS - A CRITICAL-REVIEW

      Alcohol and alcoholism
    30. PATAT A; PERAULT MC; VANDEL B; DANJOU P; BROHIER S; ZIELENIUK I; ROSENZWEIG P
      ASSESSMENT OF THE INTERACTION BETWEEN A PARTIAL AGONIST AND A FULL AGONIST OF BENZODIAZEPINE RECEPTORS, BASED ON PSYCHOMOTOR PERFORMANCE AND MEMORY, IN HEALTHY-VOLUNTEERS

      JOURNAL OF PSYCHOPHARMACOLOGY
    31. SCHWEIZER E
      GENERALIZED ANXIETY DISORDER - LONGITUDINAL COURSE AND PHARMACOLOGICAL TREATMENT

      The Psychiatric clinics of North America
    32. ORR SP; LASKO NB; PITMAN RK; SHALEV AY
      PHYSIOLOGICAL-RESPONSES TO LOUD TONES IN VIETNAM VETERANS WITH POSTTRAUMATIC-STRESS-DISORDER

      Journal of abnormal psychology
    33. DENNIS T; BEAUCHEMIN V; LAVOIE N
      ANTIDEPRESSANTS REVERSE THE OLFACTORY BULBECTOMY-INDUCED DECREASES INSPLENIC PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS IN RATS

      European journal of pharmacology
    34. SACCHETTI E; ZERBINI O; BANFI F; TANSELLA M
      OVERLAP OF BUSPIRONE WITH LORAZEPAM, DIAZEPAM AND BROMAZEPAM IN PATIENTS WITH GENERALIZED ANXIETY DISORDER - FINDINGS FROM A CONTROLLED, MULTICENTER, DOUBLE-BLIND-STUDY

      Human psychopharmacology
    35. FERRERO P; ROCCA P; MONTALENTI E; BENNA P; MILANI A; RAVIZZA L; BERGAMASCO B
      PERIPHERAL-TYPE BENZODIAZEPINE RECEPTORS ON HUMAN BLOOD MONONUCLEAR-CELLS ARE NOT REGULATED BY OVARIAN-STEROIDS

      Psychoneuroendocrinology
    36. MARAZZITI D; ROTONDO A; MARTINI C; GIANNACCINI G; LUCACCHINI A; PANCIOLIGUADAGNUCCI ML; DIAMOND BI; BORISON R; CASSANO GB
      CHANGES IN PERIPHERAL BENZODIAZEPINE RECEPTORS IN PATIENTS WITH PANICDISORDER AND OBSESSIVE-COMPULSIVE DISORDER

      Neuropsychobiology
    37. GRILLON C; AMELI R
      P300 ASSESSMENT OF ANXIETY EFFECTS ON PROCESSING NOVEL STIMULI

      International journal of psychophysiology
    38. BERGER CP; PRESSER B
      ALPRAZOLAM IN THE TREATMENT OF 2 SUBSAMPLES OF PATIENTS WITH LATE LUTEAL-PHASE DYSPHORIC DISORDER - A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY

      Obstetrics and gynecology
    39. ROSENZWEIG P; WARRINGTON S; PATAT A; ASCALONE V; BERGOUGNAN L; MORSELLI PL
      ALPIDEM - LACK OF SEDATIVE EFFECT ON PSYCHOMOTOR PERFORMANCE IN THERAPEUTIC DOSES

      Human psychopharmacology
    40. BALLENGER JC; PECKNOLD J; RICKELS K; SELLERS EM; SCHATZBERG; SHADER RI; SHEAR; WEISSMAN
      MEDICATION DISCONTINUATION IN PANIC DISORDER

      The Journal of clinical psychiatry
    41. JONAS JM; COHON MS; WEISSMAN; BARBEE JG; KRAVITZ HM; SHADER RI; GREENBLATT; SELLERS EM; SHEAR
      A COMPARISON OF THE SAFETY AND EFFICACY OF ALPRAZOLAM VERSUS OTHER AGENTS IN THE TREATMENT OF ANXIETY, PANIC, AND DEPRESSION - A REVIEW OF THE LITERATURE

      The Journal of clinical psychiatry
    42. SHADER RI; GREENBLATT DJ
      DRUG-THERAPY - USE OF BENZODIAZEPINES IN ANXIETY DISORDERS

      The New England journal of medicine
    43. PECKNOLD JC
      DISCONTINUATION REACTIONS TO ALPRAZOLAM IN PANIC DISORDER

      Journal of Psychiatric Research
    44. KATERNDAHL DA
      PANIC AND PROLAPSE - METAANALYSIS

      The Journal of nervous and mental disease
    45. LANDON JF; SHER KJ; SHAH JH
      EFFECTS OF OXAZEPAM ON ANXIETY - IMPLICATIONS FOR FOWLES PSYCHOPHYSIOLOGICAL INTERPRETATION OF GRAYS MODEL

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/02/20 alle ore 00:30:46